ArticleInternational journal of hematology2017

Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis.

Norio Komatsu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.